Skip to main content

Diana Shipping Inc(DSX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

COVID-19 Diagnostics Market Size Worth USD 8.04 Billion at 2.7% CAGR; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™

Globe NewsWire - Mon Mar 1, 2021

Pune, India, March 01, 2021 (GLOBE NEWSWIRE) -- The global COVID-19 diagnostics market size is projected to reach USD 8.04 billion by 2027, exhibiting a CAGR of 2.7% during the forecast period. Uncontrolled spread of the coronavirus worldwide will be the major factor propelling the growth of this market, shares Fortune Business Insights™ in its report, titled “COVID-19 Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Technology (PCR (Polymerase Chain Reaction), ELISA (Enzyme-linked Immunosorbent Assay), Point-of-care (POC), and Others), By Sample Type (Oropharyngeal and Nasopharyngeal Swabs, Blood, Urine, and Others), By End User (Hospitals & Clinics, Laboratories & Diagnostic Centers, Research Institutes, and Others), and Regional Forecast, 2020-2027”.

Industry Developments:

May 2020: Sofia 2 SARS Antigen FIA test developed by Quidel was green lit by the FDA, making it the first antigen test approved in the US for the detection of COVID-19. These tests identify unique protein fragments found on the outer walls of the coronavirus and deliver quick results.

March 2020: The US FDA cleared Abbott’s molecular point-of-care test for detection of COVID in patients through its Emergency Use Authorization (EUA). The test promises to deliver positive results in 5 minutes and negative results in 13 minutes.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/covid-19-diagnostics-market-103291


According to Johns Hopkins University, global COVID-19 infections reached 100,000 in just 60 days, growing to 200,000 in the next 12-14 days, and the recent addition of 100,000 cases has taken only 3 days. The calculation of the spread of this disease is based on the estimation of the “reproduction number” or R Naught (Ro). The UK Research and Innovation organization states that if the Ro goes above 1, exponential growth will be witnessed. As per a study published in the Journal of Clinical Medicine based on the virus transmission rate in Wuhan, the Ro was computed to be between 2.49 and 2.63. Such rapid transmission of the virus has surged the demand for coronavirus diagnostics tools and kits, which is boosting the growth of this market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.


Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit:https://www.fortunebusinessinsights.com/covid-19-diagnostics-market-103291


Concerted Efforts towards Developing COVID Detection Tests to Accelerate Growth

With the COVID-19 pandemic showing no signs of abatement, medical and regulatory bodies are collaborating to encourage innovation and speed up research in developing coronavirus detection tools. For instance, in April 2020, the National Institutes of Health in the US announced the launch of Rapid Acceleration of Diagnostics (RADx) initiative with a funding of USD 1.5 billion to commercialize and widen the accessibility of COVID-19 testing.

Similarly, in June 2020, the US Food and Drug Administration (FDA) joined the COVID-19 Diagnostics Evidence Accelerator created by the Friends of Cancer Research and Reagan-Udall Foundation with the aim to evaluate the performance of PCR and antibody tests for COVID. Together, these and similar initiatives are expected to augment the COVID-19 diagnostics market growth throughout 2020.

High Number of COVID-19 Cases to Give North America Leading Market Position

The United States is one of the worst-hit countries in the world by the coronavirus pandemic, with the number of cases as of June 2020 standing at 2.68 million and 129,000 deaths. In response, the US government is injecting more funds into medical research facilities to accelerate development of COVID-19 diagnostics and widen the testing net in the country. The region’s market size in 2020 stood at USD 2.20 billion.

In Europe, the virus is spreading at a furious pace, with the UK, Italy, Spain, France, and Germany having the highest number of cases. Quick adoption of advanced detection tools in the region will enable it to expand its footprint in the COVID-19 diagnostics market share in the immediate future. Heavy investments by governments in Asia Pacific in the healthcare sector are expected to favor market growth in the region.


Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/covid-19-diagnostics-market-103291


Regulatory Support to Novel Diagnostic Solutions to Encourage Innovation

The coronavirus is tightening its hold on the world and pharmaceuticals and governments are in a race against time to develop and launch quick and accurate diagnostic tests for this deadly virus. As a result, bodies such as the FDA are providing the necessary support to companies by removing unnecessary regulatory barriers, which is encouraging other players to innovate.

List of Key Players Covered in this Market Report:

  • PerkinElmer Inc. (Massachusetts, U.S)
  • Quest Diagnostics Incorporated (New Jersey, U.S)
  • Quidel Corporation (California, U.S)
  • Siemens Healthcare GmbH (Germany)
  • Abbott (Illinois, U.S)
  • Thermo Fisher Scientific Inc. (Massachusetts, U.S)
  • bioMérieux SA (France)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Danaher Corporation (Washington D.C, U.S)


Quick Buy -  COVID-19 Diagnostics Market Research Report:

https://www.fortunebusinessinsights.com/checkout-page/103291


Detailed Table of Content:

  • Introduction
    • Market Scope
    • Market Segmentation
    • Market Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Overview: Guidelines for COVID-19 Diagnosis
    • New Product Launch
    • Prevalence of COVID-19 Disease
    • Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • Global COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Product
      •  Instruments
      •  Reagents & Kits
    • Market Analysis, Insights and Forecast By Technology
      •  Polymerase Chain Reaction (PCR)
      •  Enzyme-linked Immunosorbent Assay (ELISA)
      •  Point-of-care (POC)
      •  Others
    • Market Analysis, Insights and Forecast By Sample Type
      •  Oropharyngeal & Nasopharyngeal Swabs
      •  Blood
      •  Urine
      •  Others
    • Market Analysis, Insights and Forecast By End User
      •  Hospitals & Clinics
      •  Laboratories & Diagnostic Centers
      •  Research Institute
    • Market Analysis, Insights and Forecast By Geography
      •  North America
      •  Europe
      •  Asia Pacific
      •  Latin America
      •  Middle East & Africa
  • North America COVID-19 Diagnostics Market Analysis, Insights and Forecast, 2020-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast By Product
      •  Instruments
      •  Reagents & Kits
    • Market Analysis, Insights and Forecast By Technology
      •  Polymerase Chain Reaction (PCR)
      •  Enzyme-linked Immunosorbent Assay (ELISA)
      •  Point-of-care (POC)
      •  Others
    • Market Analysis, Insights and Forecast By Sample Type
      •  Oropharyngeal & Nasopharyngeal Swabs
      •  Blood
      •  Urine
      •  Others
    • Market Analysis, Insights and Forecast By End User
      •  Hospitals & Clinics
      •  Laboratories & Diagnostic Centers
      •  Research Institute
      • Others
    • Market Analysis, Insights and Forecast  By Country
      • U.S.
      • Canada


TOC Continued….


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/covid-19-diagnostics-market-103291


Global COVID-19 Diagnostics Market Segmentation :              

By Product

  • Instruments
  • Reagents & Kits
  • By Technology
  • Polymerase Chain Reaction (PCR)
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Point-of-care (POC)
  • Others

By Sample Type

  • Oropharyngeal & Nasopharyngeal Swabs
  • Blood
  • Urine
  • Others

By End User

  • Hospital & Clinics
  • Laboratories & Diagnostics Centers
  • Research Institutes
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • The Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)


Have a Look at Related Reports:

U.S. C-arms Market Size, Share & COVID-19 Impact Analysis, By Type (Fixed C-arms, Mobile C-arms (Full-Size c-arms, Mini C-arms), By Application (Orthopedics and Trauma, Cardiology, Neurology, Gastroenterology, Oncology, and Others), By Detector (Flat Panel Detector, and Image Intensifier), By End User (Hospitals, Ambulatory Surgical Center, and Specialty Clin-ics), 2020-2027

mHealth Market Size, Share & Industry Analysis, By Category (By Apps {Disease & Treatment Management, Wellness Management}, By Wearable {Body & Temperature Monitors, Glucose Monitors}) By Services Type (Monitoring Services, Diagnostic Services, Treatment Services) By Service Provider (mHealth App Companies, Hospitals, Health Insurance) and Regional Forecast, 2019-2026

Mobility Devices Market Size, Share & Industry Analysis, By Product (Wheelchairs, Mobility Scooters, Walking Aids, and Others); By End-user (Personal Users and Institutional Users); and Regional Forecast, 2019-2026

U.S. Secondary Hyperparathyroidism (SHPT) Treatment Market Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others), and Region Forecast 2019-2026

Immune Thrombocytopenia (ITP) Market Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/global-covid-19-diagnostics-market-10100


Primary Logo

Provided Content: Content provided by Globe NewsWire. The Globe and Mail was not involved, and material was not reviewed prior to publication.